Metropolitan Life Insurance Company (MetLife)’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,554
Closed -$115K 486
2024
Q1
$115K Sell
4,554
-75
-2% -$1.89K 0.01% 975
2023
Q4
$150K Hold
4,629
0.01% 876
2023
Q3
$126K Hold
4,629
0.01% 898
2023
Q2
$103K Sell
4,629
-280
-6% -$6.23K 0.01% 1006
2023
Q1
$106K Sell
4,909
-477
-9% -$10.3K 0.01% 968
2022
Q4
$109K Hold
5,386
﹤0.01% 1003
2022
Q3
$138K Hold
5,386
0.01% 838
2022
Q2
$128K Hold
5,386
0.01% 919
2022
Q1
$121K Sell
5,386
-20,580
-79% -$463K ﹤0.01% 1079
2021
Q4
$514K Hold
25,966
0.01% 1399
2021
Q3
$511K Sell
25,966
-2,360
-8% -$46.4K 0.01% 1449
2021
Q2
$623K Buy
28,326
+1,803
+7% +$39.7K 0.01% 1371
2021
Q1
$631K Sell
26,523
-996
-4% -$23.7K 0.01% 1273
2020
Q4
$720K Sell
27,519
-2,902
-10% -$75.9K 0.01% 1113
2020
Q3
$529K Hold
30,421
0.01% 1179
2020
Q2
$512K Hold
30,421
0.01% 1177
2020
Q1
$362K Buy
30,421
+576
+2% +$6.85K 0.01% 1242
2019
Q4
$361K Sell
29,845
-1,132
-4% -$13.7K 0.01% 1528
2019
Q3
$438K Hold
30,977
0.01% 1380
2019
Q2
$345K Hold
30,977
0.01% 1529
2019
Q1
$364K Hold
30,977
0.01% 1500
2018
Q4
$414K Hold
30,977
0.01% 1312
2018
Q3
$434K Hold
30,977
0.01% 1474
2018
Q2
$487K Buy
30,977
+607
+2% +$9.54K 0.01% 1329
2018
Q1
$500K Buy
30,370
+514
+2% +$8.46K 0.01% 1275
2017
Q4
$539K Sell
29,856
-33,141
-53% -$598K 0.01% 1236
2017
Q3
$1.22M Hold
62,997
0.01% 1142
2017
Q2
$743K Buy
62,997
+6,694
+12% +$79K 0.01% 1419
2017
Q1
$617K Buy
56,303
+2,992
+6% +$32.8K ﹤0.01% 1519
2016
Q4
$387K Sell
53,311
-3,933
-7% -$28.6K ﹤0.01% 1901
2016
Q3
$372K Buy
57,244
+65
+0.1% +$422 ﹤0.01% 1901
2016
Q2
$312K Buy
57,179
+8,372
+17% +$45.7K ﹤0.01% 2007
2016
Q1
$228K Buy
48,807
+8,203
+20% +$38.3K ﹤0.01% 2093
2015
Q4
$202K Hold
40,604
﹤0.01% 2265
2015
Q3
$153K Buy
40,604
+1,975
+5% +$7.44K ﹤0.01% 2457
2015
Q2
$232K Sell
38,629
-5,373
-12% -$32.3K ﹤0.01% 2304
2015
Q1
$246K Buy
+44,002
New +$246K ﹤0.01% 1950
2014
Q2
Sell
-47,179
Closed -$206K 2773
2014
Q1
$206K Buy
+47,179
New +$206K ﹤0.01% 2440